Treating Peripheral Arterial Disease After Revascularization : Episode 2

Video

November 11, 2021

PAD Comorbidities

Marc Bonaca, MD, MPH, and Sonia Anand, MD, PhD, explain the comorbidities that increase patient risk for PAD.

EP: 1.Pathophysiology of Peripheral Arterial Disease

EP: 2.PAD Comorbidities

EP: 3.Incidence and Clinical Manifestations of PAD

EP: 4.Costs of Major Atherothrombotic Vascular Events in PAD After Revascularization

EP: 5.Advances in PAD Management: CAPRIE and DAPT Trials

EP: 6.Advances in PAD Management: EUCLID and COMPASS Trials

EP: 7.Advances in PAD Management: VOYAGER Trial

EP: 8.Antithrombotic Therapy in the PAD Post-Vascularization Setting

EP: 9.VOYAGER PAD Trial

EP: 10.Current Treatment Algorithms for PAD

EP: 11.Unmet Needs in PAD

EP: 12.Key Takeaways for Vascular Physicians

Related Videos

Sobia Laique, MD | Credit: Cleveland Clinic

What is the Global Lung Function Initiative and Its Purpose for Lung Function Testing?

Greg A. Sachs, MD I Credit: Regenstrief Institute

3 experts are featured in this series.

Pranav Garimella, MBBS, MPH | Credit: GlobalNewsWire

Related Content

Related Content

Do Not Sell My Information

Terms & Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2025 MJH Life Sciences

All rights reserved.